generic capsules and tablets

 

Published May 2017  ·  Report No. GCT828R · Price US $1,850

 


In terms of the number of unique products, generic drugs supplied  as capsules or tablets represent the largest dosage form market segment. From a competitive standpoint, while hundreds of APIs are supplied as capsules or tablets, there do exist a significant number of drugs and drug dosages that are currently being supplied by only one or two sources. These instances might represent potential opportunities for generic drug participants. This publication is designed to identify and highlight API supplier details/dosages in a manner that will allow decision makers to refine and optimize their generic drug strategies.

 

 

Report Brochure (Download PDF)

 

Report Order Form (Download PDF)

 


Generic Capsules and Tablets – Content Highlights

  • Provides analysis of generic drugs supplied as capsules and tablets and assesses key market segments and potential product opportunities
  • Presents the competitive picture for generic capsules and tablets.
  • Evaluates the importance of ANDA filing strategies and indirect ANDA acquisition on participant growth prospects
  • Analyzes the impact of patents, exclusivity and litigation on participant market sector prospects
  • Assesses the market presence and product position of the top generic tablet and capsule drug suppliers

Generic Capsules  and Tablets – Summary of Contents

Generic Markets Overview

Major Market Segments for Generic Drugs

FDA Approved Generic Drugs by Therapeutic Class

Growth in Capsules and Tablets

Demand Drivers

Evolving ANDA Filing Strategies

The Secondary Market for Buying/Selling ANDAs

Patents and Exclusivity

Litigation and First-to-File ANDA Strategies

 

Generic Capsules and Tablets – Product Considerations

Formulation Factors

Modified Release

Extended Release

Delayed Release

Specialty Dosage Forms

Chewable Tablets

Dissolvable Dosage Forms

 

Generic Capsules and Tablets – Market Details

Addiction

Anti-Infective

Antispasmodic

Antiviral

Cardiology

Dermatology

Endocrinology

Gastroenterology

Immunology

Infectious Disease

Metabolic

Nephrology

Neurology

NSAIDs

Oncology

Ophthalmology

Osteoporosis

Pain Management

Reproductive Health

Urology

Company Analysis

 

Key Capsule/Tablet Generic Drug Opportunity Factors

Saturation Index

API Opportunity Index

P(iv) Capsule/Tablet Drug Index

Orange Book Capsule/Tablet Drug Patent Staircase Analysis